Our Partners

Own commercialization in the US and the Nordic region, strategic partnerships for Hexvix®/Cysview® in Europe, Canada, Australia and New Zealand.

  • Ipsen Pharma

    In September 2011, Photocure entered into a strategic collaboration with Ipsen for the commercialization of Hexvix® in Europe, excluding the Nordic region.

    Ipsen commercializes Hexvix® through its dedicated urology specialists. Ipsen has its headquarter in Paris, France.

    Ipsen web page

  • Juno Pharmaceuticals

    In 2Q 2015, Photocure entered into an exclusive distribution agreement with Juno Pharmaceuticals, for the registration and commercialization of Hexvix® in Australia and New Zealand.

    Juno web page

  • BioSyent Pharma Inc

    In 3Q 2015, Photocure entered into an exclusive distribution agreement with BioSyent Pharma Inc. for the commercialization of Cysview® in Canada.

    BioSyent web page

  • Combat Medical

    In August 2018, Photocure entered into an exclusive distribution deal for the Nordic area with Combat Medical Ltd for distribution of their patented medical device. This innovative and highly automated device delivers heated therapy to bladder cancer patients, and fits very well into the bladder cancer expertise and current Hexvix® business.

    Combat Medical web page